• All-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic 

      Alnuaimi, Asma A.; Chemaitelly, Hiam; Semaan, Sandy; Almukdad, Sawsan; Al-Kanaani, Zaina; ... more authors ( BMJ Publishing Group , 2023 , Article)
      Objective To investigate all-cause mortality, COVID-19 mortality and all-cause non-COVID-19 mortality in Qatar during the COVID-19 pandemic. Methods A national, retrospective cohort analysis and national, matched, retrospective ...
    • Bacteremia and septicemia in Qatar 

      Al-Thani, Asma ( Ministry of Defence And Aviation , 1999 , Article)
      Objectives: The aims of the study are to define the pattern of bacteremia and septicemia in Hamad Medical Corporation in relation to the susceptibility of the implicated microbes to various antimicrobial agents. Methods: ...
    • Canavan disease: an Arab scenario. 

      Zayed, Hatem ( Elsevier Inc. , 2015 , Article)
      The autosomal recessive Canavan disease (CD) is a neurological disorder that begins in infancy. CD is caused by mutations in the gene encoding the ASPA enzyme. It has been reported with high frequency in patients with ...
    • Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden 

      Turk-Adawi, Karam; Sarrafzadegan, Nizal; Fadhil, Ibtihal; Taubert, Kathryn; Sadeghi, Masoumeh; ... more authors ( Nature Publishing Group , 2017 , Article Review)
      The Eastern Mediterranean region (EMR) comprises 22 countries or territories spanning from Morocco in the west to Pakistan in the east, and contains a population of almost 600 million people. Like many other developing ...
    • Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar. 

      Chemaitelly, Hiam; Ayoub, Houssein H; AlMukdad, Sawsan; Coyle, Peter; Tang, Patrick; ... more authors ( Nature Research , 2022 , Article)
      SARS-CoV-2 Omicron BA.1 and BA.2 subvariants are genetically divergent. We conducted a matched, test-negative, case-control study to estimate duration of protection of the second and third/booster doses of mRNA COVID-19 ...
    • Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar 

      Elias, Tayar; Abdeen, Sami; Abed Alah, Muna; Chemaitelly, Hiam; Bougmiza, Iheb; ... more authors ( Elsevier , 2023 , Article)
      BackgroundSome studies have reported that influenza vaccination is associated with lower risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and/or coronavirus disease 2019 (COVID-19) morbidity ...
    • Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar 

      Ahmed, Zaqout; Almaslamani, Muna A.; Chemaitelly, Hiam; Hashim, Samar A.; Ittaman, Ajithkumar; ... more authors ( Elsevier , 2022 , Article)
      ObjectivesTo estimate the real-world effectiveness of sotrovimab against severe, critical, or fatal COVID-19 in Qatar at a time in which most SARS-CoV-2 incidences occurred due to the BA.2 Omicron subvariant. MethodsWe ...
    • Epidemiology of herpes simplex virus type 2 in Europe: systematic review, meta-analyses, and meta-regressions 

      Alareeki, Asalah; Osman, Aisha M.M.; Khandakji, Mohannad N.; Looker, Katharine J.; Harfouche, Manale; ... more authors ( Elsevier , 2023 , Article)
      Background: Herpes simplex virus type 2 (HSV-2) infection is a globally prevalent, life-long, sexually transmitted infection. This study characterized HSV-2 seroprevalence in Europe for various at-risk populations and ...
    • Epidemiology of respiratory infections among adults in Qatar (2012-2017). 

      Al-Romaihi, Hamad Eid; Smatti, Maria K; Ganesan, Nandakumar; Nadeem, Shazia; Farag, Elmoubasher; ... more authors ( Public Library of Science , 2019 , Article)
      Limited data is available about the etiology of influenza like illnesses (ILIs) in Qatar. This study aimed at providing preliminary estimates of influenza and other respiratory infections circulating among adults in Qatar. ...
    • Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020 

      Houssein H., Ayoub; Mumtaz, Ghina R.; Seedat, Shaheen; Makhoul, Monia; Chemaitelly, Hiam; ... more authors ( Elsevier , 2021 , Article)
      We aimed to estimate, albeit crudely and provisionally, national, regional, and global proportions of respective populations that have been infected with SARS-CoV-2 in the first year after the introduction of this virus ...
    • Genetic epidemiology of ovarian cancer in the 22 Arab countries: A systematic review. 

      Younes, Nadin; Zayed, Hatem ( Elsevier , 2019 , Article)
      Ovarian cancer (OC) is a common disease among Arabs, with one of the highest incidences in the world. OC is underdiagnosed, underreported, and mostly reported with breast cancer. This study aimed to conduct a systematic ...
    • Geographic, gender and seasonal variation of diabetes: a nationwide study among 1.4 million participants. 

      Zhang, Yuanfeng; Tong, Mingkun; Wang, Bo; Shi, Zumin; Wang, Ping; ... more authors ( Oxford University Press , 2021 , Other)
      China experienced a rapid increase in the prevalence of diabetes. To assess the prevalence of diabetes among Chinese adults who attend preventive physical examination, and analyzed geographical and gender difference in ...
    • Molecular epidemiology of influenza, RSV, and other respiratory infections among children in Qatar: A six years report (2012–2017) 

      Al-Romaihi, Hamad E.; Smatti, Maria K.; Al-Khatib, Hebah A.; Coyle, Peter V.; Ganesan, Nandakumar; ... more authors ( Elsevier B.V. , 2020 , Article)
      Background: Studies on the etiology of respiratory infections among children in Qatar and surrounding countries are limited. Objectives: To describe the prevalence and seasonality of RSV, influenza, and other respiratory ...
    • mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar 

      Chemaitelly, Hiam; Yassine, Hadi M.; Benslimane, Fatiha M.; Al Khatib, Hebah A.; Tang, Patrick; ... more authors (2021 , Article)
      The SARS-CoV-2 pandemic continues to be a global health concern. The mRNA-1273 (Moderna) vaccine was reported to have an efficacy of 94.1% at preventing symptomatic COVID-19 due to infection with ‘wild-type’ variants in a ...
    • Negative epidemiological association between HSV-1 and HSV-2 infections 

      Nasrallah, Gheyath; Dargham, Soha; Laith, Abu-Raddad ( Elsevier , 2019 , Article)
      Objectives: Existing evidence on an epidemiological association between herpes simplex virus (HSV) type 1 and type 2 infections remains conflicting and inconclusive. Using a multi-national database of HSV-1/2 serologica ...
    • Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study 

      Suelen H., Qassim; Chemaitelly, Hiam; Ayoub, Houssein H.; Coyle, Peter; Tang, Patrick; ... more authors ( Elsevier , 2023 , Article)
      BackgroundWaning of natural infection protection and vaccine protection highlight the need to evaluate changes in population immunity over time. Population immunity of previous SARS-CoV-2 infection or of COVID-19 vaccination ...
    • Prevalence of hepatitis A virus among migrant workers in Qatar: A national study 

      Younes, Nadin; Chemaitelly, Hiam; Nizamuddin, Parveen Banu; Al-Hamad, Tasneem; Abdallah, Marah; ... more authors ( Public Library of Science , 2024 , Article)
      Background Hepatitis A virus (HAV) is the predominant cause of acute viral hepatitis worldwide; however, data on HAV antibody prevalence (seroprevalence) among migrant populations are limited. This study aimed to investigate ...
    • Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage 

      Chemaitelly, Hiam; Ayoub, Houssein H.; Coyle, Peter; Tang, Patrick; Yassine, Hadi M.; ... more authors ( Nature Research , 2022 , Article)
      There is significant genetic distance between SARS-CoV-2 Omicron (B.1.1.529) variant BA.1 and BA.2 sub-lineages. This study investigates immune protection of infection with one sub-lineage against reinfection with the other ...
    • SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy 

      Laith J., Abu-Raddad; Chemaitelly, Hiam; Coyle, Peter; Malek, Joel A.; Ahmed, Ayeda A.; ... more authors ( Elsevier , 2021 , Article)
      Background Reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been documented, raising public health concerns. SARS-CoV-2 reinfections were assessed in a cohort of antibody-positive persons ...
    • Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study 

      Hiam, Chemaitelly; Faust, Jeremy Samuel; Krumholz, Harlan M.; Ayoub, Houssein H.; Tang, Patrick; ... more authors ( Elsevier , 2023 , Article)
      ObjectivesWe assessed short-, medium-, and long-term all-cause mortality risks after a primary SARS-CoV-2 infection. MethodsA national, matched, retrospective cohort study was conducted in Qatar to assess risk of all-cause ...